Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial

BACKGROUND: Short-acting β(2)-agonist (SABA) bronchodilators help alleviate symptoms in chronic obstructive pulmonary disease (COPD) and may be a useful marker of symptom severity. This analysis investigated whether SABA use impacts treatment differences between maintenance dual- and mono-bronchodil...

Descripción completa

Detalles Bibliográficos
Autores principales: Maltais, F., Naya, I. P., Vogelmeier, C. F., Boucot, I. H., Jones, P. W., Bjermer, L., Tombs, L., Compton, C., Lipson, D. A., Kerwin, E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579818/
https://www.ncbi.nlm.nih.gov/pubmed/33092591
http://dx.doi.org/10.1186/s12931-020-01451-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579818/
https://www.ncbi.nlm.nih.gov/pubmed/33092591
http://dx.doi.org/10.1186/s12931-020-01451-8

Ejemplares similares